Hypersialylation in Cancer: Modulation of Inflammation and Therapeutic OpportunitiesEmily Rodrigues, Matthew S. Macauley|Cancers|2018Cited by 238
Glycoengineering of NK Cells with Glycan Ligands of CD22 and Selectins for B‐Cell Lymphoma TherapySenlian Hong, Peng Wu, John R. Yates et al.|Angewandte Chemie International Edition|2020Cited by 82
Reshaping the tumor microenvironment by degrading glycoimmune checkpoints Siglec-7 and -9Chao Wang, Peng Wu, Ding Zhang et al.|bioRxiv (Cold Spring Harbor Laboratory)|2024Cited by 14